Cargando…
MicroRNA therapeutics in cardiovascular medicine
Cardiovascular diseases are the most common causes of human morbidity and mortality despite significant therapeutic improvements by surgical, interventional and pharmacological approaches in the last decade. MicroRNAs (miRNAs) are important and powerful mediators in a wide range of diseases and thus...
Autor principal: | Thum, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376835/ https://www.ncbi.nlm.nih.gov/pubmed/22162462 http://dx.doi.org/10.1002/emmm.201100191 |
Ejemplares similares
-
Preclinical and Clinical Development of Noncoding RNA Therapeutics for Cardiovascular Disease
por: Huang, Cheng-Kai, et al.
Publicado: (2020) -
microRNA‐based diagnostic and therapeutic applications in cancer medicine
por: Sempere, Lorenzo F., et al.
Publicado: (2021) -
MicroRNA and Cardiovascular Diseases
por: Çakmak, Hüseyin Altuğ, et al.
Publicado: (2020) -
MicroRNAs as therapeutic targets in cardiovascular disease
por: Laggerbauer, Bernhard, et al.
Publicado: (2022) -
MicroRNAs and cardiovascular medicine
por: Kaur, Upinder, et al.
Publicado: (2014)